In schizophrenia, the gene expression of complement pathway activators (C1qA) and mediators (C3 or C4) was increased in the midbrain, especially in patients with inflammatory biotypes (Purves-Tyson et al., 2020). This evidence concerns the gene C1QA and schizophrenia.